BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 31315669)

  • 1. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
    Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
    Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene.
    Lanzi G; Ferraro RM; Masneri S; Piovani G; Barisani C; Sobacchi C; Villa A; Vezzoni P; Giliani S
    Stem Cell Res; 2020 Jan; 42():101660. PubMed ID: 31794943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells (ARO-iPSC1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212+1G>T mutation in SNX10 gene.
    Xu M; Stattin EL; Murphy M; Barry F
    Stem Cell Res; 2017 Oct; 24():51-54. PubMed ID: 29034896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells.
    Ou M; Li C; Tang D; Xue W; Xu Y; Zhu P; Li B; Xie J; Chen J; Sui W; Yin L; Dai Y
    Stem Cell Res Ther; 2019 Aug; 10(1):251. PubMed ID: 31412925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells.
    Xian X; Moraghebi R; Löfvall H; Fasth A; Henriksen K; Richter J; Woods NB; Moscatelli I
    Stem Cell Res Ther; 2020 May; 11(1):179. PubMed ID: 32414402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts.
    Neri T; Muggeo S; Paulis M; Caldana ME; Crisafulli L; Strina D; Focarelli ML; Faggioli F; Recordati C; Scaramuzza S; Scanziani E; Mantero S; Buracchi C; Sobacchi C; Lombardo A; Naldini L; Vezzoni P; Villa A; Ficara F
    Stem Cell Reports; 2015 Oct; 5(4):558-68. PubMed ID: 26344905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs.
    Li D; Ou M; Zhang W; Luo Q; Cai W; Mo C; Liang W; Dai G; Yin L; Zhu P; Tang D; Dai Y
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):131. PubMed ID: 37395026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.
    Chen W; Twaroski K; Eide C; Riddle MJ; Orchard PJ; Tolar J
    J Bone Joint Surg Am; 2019 Nov; 101(21):1939-1947. PubMed ID: 31567691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.
    Chen YS; Pelekanos RA; Ellis RL; Horne R; Wolvetang EJ; Fisk NM
    Stem Cells Transl Med; 2012 Feb; 1(2):83-95. PubMed ID: 23197756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of whole exome sequencing for the diagnosis of autosomal recessive malignant infantile osteopetrosis.
    Shamriz O; Shaag A; Yaacov B; NaserEddin A; Weintraub M; Elpeleg O; Stepensky P
    Clin Genet; 2017 Jul; 92(1):80-85. PubMed ID: 27187610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
    Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
    Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
    Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
    Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche.
    Zeytin IC; Alkan B; Ozdemir C; Cetinkaya DU; Okur FV
    Stem Cells Transl Med; 2022 Mar; 11(3):310-321. PubMed ID: 35356978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis.
    Moscatelli I; Thudium CS; Flores C; Schulz A; Askmyr M; Gudmann NS; Andersen NM; Porras O; Karsdal MA; Villa A; Fasth A; Henriksen K; Richter J
    Bone; 2013 Nov; 57(1):1-9. PubMed ID: 23907031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.